For most individuals with Atrial Fibrillation (AFib), blood thinner treatment is lifelong. The primary goal is to continuously reduce the long-term, ongoing risk of stroke, as the risk often outweighs the risk of bleeding for most patients.
Your doctor may want you to take a blood thinner for a few weeks before and after you have an AFib treatment called cardioversion. Cardioversion delivers an electrical shock to your heart that can bring it back into a normal rhythm. If it works for you, you may not need to take a blood thinner long-term.
Some patients taking Eliquis may experience nausea, dizziness, or headaches as side effects. These symptoms usually subside once your body adjusts to the medication. However, if they persist or become bothersome, consult your healthcare professional for advice on how to manage them.
Stopping blood thinners can increase your risk for blood clots, due to the underlying risk factor(s) for which your blood thinner was originally prescribed. Many times, these bleeding and clotting risks can be complicated for you to understand, and difficult for your healthcare providers to manage.
rash, itching or hives on the skin. swelling of the hands, ankles or feet due to water retention. Call your doctor straight away or go straight to the Emergency Department at your nearest hospital if you notice any of these serious side effects.
Common Eliquis Side Effects
The most common side effect of Eliquis is bleeding. The risk of non-major bleeding is 2% to 4%, and the risk of major bleeding is 3% or less. Other common Eliquis side effects include: Bleeding from cuts that takes longer to stop.
Interactions between your drugs
There were no interactions found between Eliquis and Metoprolol Succinate ER.
The 1-3-6-12 rule is a clinical guideline for timing the restart of anticoagulation after an ischemic stroke or transient ischemic attack (TIA), delaying treatment based on stroke severity (TIA=Day 1, Minor=Day 3, Moderate=Day 6, Severe=Day 12) to balance bleeding risk against stroke recurrence, though newer studies, like the TIMING trial, and ELAN trial,, suggest earlier initiation might be safe and effective, challenging the traditional longer delays.
The Watchman device offers a revolutionary alternative to blood thinners. This compact implant — about the size of a quarter — provides lifelong protection, keeping harmful, stroke-causing blood clots from forming, thus replacing the need for prescription blood thinners.
In a Kaplan‐Meier analysis, patients who were treated with warfarin had a mean life expectancy of 52.0 months, whereas those who were not treated with warfarin had a corresponding life expectancy of 38.2 months (Δ = 13.8 months, p < 0.001) (fig 1).
“Although rare,” notes Clocchiatti-Tuozzo, “a potential side effect [of Eliquis] is an increased risk of bleeding with intracranial hemorrhage being one of the rarest, but most feared, complications of this drug.”
Ibuprofen and Naproxen
Your chance of bleeding increases if you combine NSAID with Eliquis. Though the bleeding incident can be minor, it can also be fatal. You should always consult your doctor for any medication and take the safest drug possible.
Does Eliquis lower blood pressure? No, Eliquis does not affect blood pressure. However, increased bleeding caused by Eliquis could cause a decrease in your red blood cell count (anemia) or lower platelet count (thrombocytopenia), which can cause other side effects like fatigue, dizziness, and weakness.
The 30-second rule in atrial fibrillation (AFib) is a widely used, though debated, guideline defining an AFib episode as an irregularly irregular heart rhythm lasting at least 30 seconds on an ECG, used to distinguish it from shorter, less significant atrial arrhythmias and help guide diagnosis and treatment, particularly for stroke risk and ablation success. While a standard for trials and device monitoring, newer research suggests shorter runs of AF might still be clinically important, prompting ongoing discussion about whether this threshold accurately reflects stroke risk and overall AF burden.
If you have atrial fibrillation (AFib), you have a higher chance of developing blood clots, which significantly increase your risk for a stroke. Your doctor may suggest taking blood thinners to combat this danger.
The erratic electrical impulses that cause afib make the heart work harder and can lead to heart failure. This can result from being left in afib for too long, especially with a high heart rate. The heart becomes enlarged, ineffective, and weak, causing it to be unable to pump oxygenated blood throughout the body.
Without blood thinners, the risk of someone with AFib having a stroke averages about 2.3 percent per year or 20 percent over 10 years. As we talked about previously, the trade-off of preventing these strokes is major bleeding, which occurs in 2 percent of patients annually taking blood thinners.
Blood clots that form in the left atrium can leave the heart and travel to the brain, resulting in a stroke. There are two main types of A-fib: Paroxysmal (or intermittent) A-fib – Episodes occur with varying frequency and duration but resolve on their own within seven days.
A 2022 study published in the Annals of Internal Medicine found apixaban to be the safest blood thinner among direct oral anticoagulants (DOACs), with the lowest risk of gastrointestinal bleeding.
In general, oral anticoagulation is preferred in patients with CHA2DS2-VASc score ≥2, and no anticoagulation in patients with a score of 0 (see Figure 1 and Table 1). In patients with CHA2DS2-VASc score of 1, anticoagulation should be individualised as the risk of stroke is low.
Indefinite anticoagulation is often chosen if there is a low risk of bleeding, whereas anticoagulation is usually stopped at 3 months if there is a high risk of bleeding.
Stroke Risk Assessment (CHADS2, CHA2DS2-VASc)
If the CHADS2 score is 0-1, other stroke risk modifiers could be considered to determine whether or not to use oral anticoagulants. Recommendations for anticoagulation based on CHADS2 and CHA2DS2-VASc are the same: oral anticoagulation is recommended for a score of ≥ 2.
Metoprolol can interact with medications and other substances. Examples include digoxin, diphenhydramine, and certain calcium channel blockers. It can also interact with clonidine, certain antidepressants, and alcohol. Most commonly, you may experience dizziness and lightheadedness from a metoprolol interaction.
Eliquis interactions include:
Two drugs that can't be taken together include opioids and alcohol, or benzodiazepines and alcohol, as this combination severely slows breathing and increases overdose risk, and also aspirin and ibuprofen (or other NSAIDs), which heighthens the danger of serious bleeding or stomach ulcers, highlighting the importance of checking all medications for dangerous interactions.